Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
B6125 AcetazolamideSummary: carbonic anhydrase (CA) inhibitor
-
B6128 Fenofibric acidSummary: ppar inhibitor, lipid-lowering agent
-
B6134 Amodiaquine dihydrochloride dihydrateSummary: histamine N-methyl transferase inhibitor
-
B6153 IsatinSummary: endogenous monoamine oxidase inhibitor
-
B6154 BenzenesulfonamideSummary: carbonic anhydrase inhibitor
-
B6155 Lauric AcidSummary: saturated medium-chain fatty acid
-
B7804 AG-221 (Enasidenib)Summary: mutant isocitrate dehydrogenase 2 (IDH2) inhibitor
-
B7805 AG-120Summary: mutant IDH1 inhibitor
-
B7824 ML390Summary: human DHODH inhibitor
-
B7827 3,4-DAASummary: synthetic derivative of the tryptophan metabolite anthranilic acid